Researchers have found a substitute for insulin to help treat diabetes orally, replacing painful pricks. Over 10 years, Erik Helmerhorst, professor at Curtin University, and colleagues looked at three million compounds on pharmaceutical databases to try to emulate the molecular map of insulin. They found one, and are developing it to 'take the needle out of diabetes'. "Our innovation is the development of a new chemical entity, a small drug molecule we have discovered and developed, that can be taken orally as a tablet to replace insulin per se," said Helmerhorst. The research has the ability to revolutionise the treatment of diabetes, which is a growing problem worldwide. Helmerhorst said there was a niche market for their drug molecule to target Type 2 diabetics to help delay the onset of insulin dependency, according to a Curtin statement. He said 95 percent of diabetics have Type 2 diabetes; they last year spent some $10 billion on insulin. "The reality is that nearly one-third of Type 2 diabetics will end up needing insulin therapy at some stage," he said. According to the scientist, the insulin substitute would appeal to people who were averse to taking insulin via injections or by pumps. Helmerhorst outlined his team's quest at the Univation 2011 conference in Perth Nov 2-3.
GMT 13:50 2018 Tuesday ,30 October
Emergency surgery saves life of touristGMT 13:20 2018 Monday ,29 October
National campaign to raise awareness of breast cancerGMT 14:34 2018 Friday ,19 October
Birth spacing "improving health of Omani women"GMT 15:35 2018 Thursday ,11 October
Russia to discuss issue of biological labs near its bordersGMT 16:14 2018 Saturday ,29 September
Premier Khalifa bin Salman congratulated by health ministerGMT 16:10 2018 Saturday ,29 September
Bahrain to host Dermatology, Laser and Aesthetics ConferenceGMT 12:44 2018 Friday ,28 September
EU proposes €40 million for UNRWA to keep health clinics openGMT 07:46 2018 Wednesday ,26 September
HRH Premier to address UN high-level health meetingsMaintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2021 ©
Maintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2021 ©
Send your comments
Your comment as a visitor